CARM (Carisma Therapeutics Inc.) Short-Term Debt to Capital
Carisma Therapeutics (CARM) ensures the flawless delivery of biomaterials for the creation of advanced drugs, guaranteeing stable profits. The company is scaling its targeted macrophage platform by collaborating with industry leaders to combat tumors. This price action chart featuring the 0.00 metric complements the analysis of the top management's performance, as they implement breakthrough cell therapy methods for the global medical community.
Analytical breakdowns for Carisma Therapeutics
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital Carisma Therapeutics|CARM - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Carisma Therapeutics|CARM - Aggregate Debt Obligations|Debts to Book Capitalization Carisma Therapeutics Inc|CARM - Long-Term Debt Volume|Company Short-Term Debt Carisma Therapeutics|Quick Liquidity carismatx.com
- company profitability and valuation multiples indicators:
Fundamental valuation:Carisma Therapeutics Inc.
Investors must evaluate the asset's financial stability by analyzing the short-term debt-to-equity ratio, which determines the company's level of dependence on borrowed funds. The current short-term debt to equity value reflects the ability of Carisma Therapeutics (CARM) to fund the development of CAR-macrophages for solid tumor therapy without excessive debt pressure that could limit investments in innovation.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KalVista Pharmaceuticals Inc - Short-Term Debt to Capital|Septerna Pharma (SEPN) - Short-Term Debt to Equity Ratio|PVLA: Short-Term Debt to Capital|savarapharma.com (SVRA) - Short-Term Debt to Capital|Short-Term Debt to Equity Rigel Pharmaceuticals, Inc.|ANAB: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ATXS|Short-Term Debt to Capital Coefficient enGene Corp|Short-Term Debt to Equity RAPT Therapeutics RAPT|Short-Term Debt to Capital Coefficient Aerovate Therapeutics, Inc. (JBIO)|ACRS - Short-Term Debt to Equity|Kyverna Therapeutics Inc. (KYTX) - Short-Term Debt to Equity Ratio|TLSA: Short-Term Debt to Capital|Cabaletta Bio Inc (CABA) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio VTYX|THTX: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio AVTX (Avalo Therapeutics)|Short-Term Loans to Capital Ratio ELDN|Short-Term Debt to Capital AGEN (Agenus Inc)|Ratio of Short-Term Indebtedness to Capital CLYM|Zura Bio - Short-Term Debt to Capital|Current Liabilities to Capital atyrpharma.com|adagene.com (ADAG) - Short-Term Debt to Equity|Ikena Oncology - Ratio of Short-Term Indebtedness to Capital|STTK (Shattuck Labs Inc) - Short-Term Debt to Capital|Short-Term Debt to Capital Equillium Bio|Short-Term Debt to Equity Connect Biopharma (CNTB)|IMUX: Current Liabilities to Equity|Short-Term Debt to Capital ATRA (Atara Bio)|InflaRx NV (IFRX) - Current Liabilities to Capital|XFOR: Short-Term Debt to Equity Ratio|ACET - Short-Term Debt to Capital|CELU (celularity.com) - Short-Term Debt to Equity Ratio|INMB: Short-Term Loans to Capital Ratio|BRNS (Barinthus Biotherapeutics plc) - Short-Term Debt to Capital|Kezar Life Sciences Inc. (KZR) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital SABS|Short-Term Debt to Equity Ratio Akari Therapeutics, Plc AKTX|Short-Term Debt to Equity Enlivex Therapeutics Ltd. ENLV|Short-Term Debt to Capital Coefficient Q32 Bio Inc (QTTB)|GeoVax - Short-Term Debt to Capital|Edesa Biotech Inc (EDSA) - Short-Term Debt to Equity Ratio|IBIO: Short-Term Debt to Capital|XTL Bio (XTLB) - Short-Term Debt to Capital|Short-Term Debt to Equity Bolt Biotherapeutics Inc.|HCWB: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Aptevo Therapeutics (APVO)|Short-Term Debt to Equity Ratio aimimmuno.com AIM|Short-Term Debt to Equity Aditxt, Inc. ADTX|GRI (GRI Bio Corporation) - Current Liabilities to Equity|XORTX Therapeutics Inc. - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital HIND (reshapelifesciences.com)|REVB: Short-Term Debt to Capital|Indaptus Therapeutics Inc (INDP) - Short-Term Debt to Capital|Short-Term Debt to Equity Scinai|CALI: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Affimed (AFMD)|Short-Term Debt to Equity Ratio allakos.com ALLK|Short-Term Debt to Capital HOOK (HOOKIPA Pharma)|Short-Term Debt to Capital IGM Biosciences Inc. IGMS|ITOS: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital OCEA (Ocean Biomedical Corp)|TCBP: Short-Term Debt to Capital|THRD - Short-Term Debt to Capital Coefficient